Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02313636
Other study ID # DaBlaCa-7
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2014
Est. completion date November 2015

Study information

Verified date May 2023
Source Aarhus University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Patients with first time hematuria or patients previously diagnosed with papillomas/CIS of the bladder are included in the study. All surgeons are highly experienced in WL cystoscopy and familiar with NBI findings. Cystoscopy is performed with HD cameras and Olympus light sources. First, a systematic cystoscopy is made in WL. Secondly, the clinical decision is noted. After WL, the cystoscopy is made with NBI and any potential subsequent change in the clinical decision is noted. A total number of 896 patients is planned to be included.


Recruitment information / eligibility

Status Completed
Enrollment 955
Est. completion date November 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing flexible cystoscopy because of haematuria or previous NMIBC Exclusion Criteria: - Patients not fullfilling the above

Study Design


Related Conditions & MeSH terms

  • Narrow Band Imaging in Flexible Cystoscopy

Locations

Country Name City State
Denmark Aarhus University Hospital Århus N
Denmark Herlev Hospital Herlev
Denmark Hospitalsenheden Vest Holstebro

Sponsors (4)

Lead Sponsor Collaborator
Aarhus University Hospital Herlev Hospital, Hospitalsenheden Vest, Oslo University Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary change in the clinical decision Baseline